avVaa World Health Care Products will launch a two week DRTV test run for Neuroskin(R) Psoriasis Relief beginning the week of
"With the hard offer, the price is given up front, and many customers like that," stated
The DRTV commercials are in infomercial format. Over 50 commercials will run each week, most being 2 minutes long. "Synergixx is working with the networks to get us additional free spots for 60 and 30 second commercials," commented Mrs. Campbell-Farley. To facilitate this, Creative Bube Tube has added a 30 second DRTV commercial to Neuroskin's(R) DRTV repertoire.
"With our first media test, we were able to work out the kinks in our processes and in vendor communications. We took what we learned and made the changes that were needed, such as changing media buyers, adding echeck, and streamlining our credit card processing. We're ready to hit the road running with this test, and we anticipate a much better return on our investment," concluded
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products through mass, food and drug channels in
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
CONTACT:
SOURCE avVaa World Health Care Products